| Ticker | MRNA |
|---|---|
| ISIN | US60770K1079 |
| Sector | Atención sanitaria |
| Industria | Biotechnology |
| Mercado | NYSE |
| Capitalización | S/18,695,104,675 |
| Beta | 1,34 |
| Sitio web | https://www.modernatx.com |
| CEO | Stéphane Bancel |
| Fecha de IPO | 07/12/2018 |
| País | US |
| Dirección | 325 Binney Street, Cambridge, MA, 02142 |
| Volumen | 3.639.207 |
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency vi...
Moderna opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones